GRASSI, GUIDO
 Distribuzione geografica
Continente #
NA - Nord America 64.356
EU - Europa 27.154
AS - Asia 16.486
SA - Sud America 1.053
AF - Africa 219
OC - Oceania 74
Continente sconosciuto - Info sul continente non disponibili 63
Totale 109.405
Nazione #
US - Stati Uniti d'America 63.297
SG - Singapore 6.351
RU - Federazione Russa 5.566
CN - Cina 4.467
SE - Svezia 3.969
IE - Irlanda 3.761
HK - Hong Kong 3.686
DE - Germania 3.660
IT - Italia 3.605
UA - Ucraina 2.601
GB - Regno Unito 1.268
CA - Canada 921
BR - Brasile 851
FI - Finlandia 750
FR - Francia 472
VN - Vietnam 454
AT - Austria 439
ID - Indonesia 342
IN - India 338
TR - Turchia 247
NL - Olanda 238
DK - Danimarca 177
BE - Belgio 108
MX - Messico 98
JP - Giappone 89
PL - Polonia 80
ZA - Sudafrica 75
CZ - Repubblica Ceca 70
IR - Iran 67
KR - Corea 62
AU - Australia 58
ES - Italia 50
EU - Europa 50
RO - Romania 49
TW - Taiwan 46
GR - Grecia 43
AR - Argentina 38
PK - Pakistan 36
PT - Portogallo 35
VE - Venezuela 35
IQ - Iraq 33
PH - Filippine 33
CL - Cile 32
CH - Svizzera 31
EC - Ecuador 31
PE - Perù 28
BG - Bulgaria 24
CO - Colombia 24
UZ - Uzbekistan 24
BD - Bangladesh 23
AE - Emirati Arabi Uniti 21
MA - Marocco 21
TN - Tunisia 21
EG - Egitto 19
NG - Nigeria 18
SK - Slovacchia (Repubblica Slovacca) 18
TH - Thailandia 18
HU - Ungheria 17
LT - Lituania 17
KE - Kenya 16
LK - Sri Lanka 16
NZ - Nuova Zelanda 16
KZ - Kazakistan 15
LV - Lettonia 15
MY - Malesia 15
NO - Norvegia 15
SA - Arabia Saudita 15
AL - Albania 13
KG - Kirghizistan 12
MU - Mauritius 12
AZ - Azerbaigian 11
A2 - ???statistics.table.value.countryCode.A2??? 10
BY - Bielorussia 10
RS - Serbia 10
IL - Israele 9
MK - Macedonia 9
AM - Armenia 8
CM - Camerun 8
EE - Estonia 8
LB - Libano 8
BO - Bolivia 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
JO - Giordania 7
BA - Bosnia-Erzegovina 6
MD - Moldavia 6
MN - Mongolia 6
PA - Panama 6
BJ - Benin 5
KH - Cambogia 5
HR - Croazia 4
JM - Giamaica 4
NP - Nepal 4
SV - El Salvador 4
BH - Bahrain 3
BN - Brunei Darussalam 3
GY - Guiana 3
LU - Lussemburgo 3
PR - Porto Rico 3
PY - Paraguay 3
Totale 109.349
Città #
Ann Arbor 12.308
Fairfield 6.263
Woodbridge 6.101
Houston 4.545
Singapore 4.157
Hong Kong 3.648
Dublin 3.590
Chandler 3.314
Ashburn 3.104
Wilmington 2.851
Jacksonville 2.827
Seattle 2.574
Frankfurt am Main 2.211
Dearborn 2.031
Cambridge 2.011
Princeton 1.646
New York 1.563
Santa Clara 1.147
Milan 1.068
Lawrence 778
Altamura 723
Nanjing 688
Beijing 656
Lachine 459
San Diego 420
Shanghai 415
Hangzhou 409
Vienna 350
Moscow 319
Jakarta 283
Andover 277
Boardman 248
Nanchang 240
Helsinki 236
Guangzhou 224
Shenyang 199
Toronto 198
Hebei 191
Council Bluffs 190
Dong Ket 189
Ottawa 175
Los Angeles 150
Tianjin 146
Jiaxing 137
Falls Church 136
Changsha 135
London 133
Norwalk 123
Jinan 116
Lissone 112
Fremont 108
Nuremberg 107
São Paulo 96
Rome 93
Brussels 90
Mountain View 75
Kunming 74
Ningbo 67
Huizen 65
San Mateo 63
Zhengzhou 63
Chicago 61
Pune 58
Munich 56
Brno 54
Düsseldorf 54
Monza 54
Washington 52
Redmond 51
Lappeenranta 48
Philadelphia 47
Hefei 46
Nürnberg 46
Istanbul 44
Dallas 43
Detroit 39
University Park 34
Edmonton 33
Cinisello Balsamo 31
Sacramento 31
Fuzhou 30
Taizhou 30
Auburn Hills 29
Amsterdam 27
Carate Brianza 27
Kiev 27
Mumbai 27
Naples 27
Leawood 25
Belo Horizonte 24
Hyderabad 24
Taiyuan 24
Bologna 23
Kraków 23
Monmouth Junction 23
Rio de Janeiro 23
Wuhan 23
Hounslow 22
Lima 22
Phoenix 22
Totale 78.299
Nome #
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) 766
'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: Morphological criteria and clinical impact 388
Big data, observational research and P-value: a recipe for false-positive findings? A study of simulated and real prospective cohorts 319
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 317
Sex-related relationships between uric acid and target organ damage in hypertension 314
Heart rate as a sympathetic marker during acute adrenergic challenge 313
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 298
Hemodynamic effects of acute and prolonged administration of nitrendipine in essential hypertension 295
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 283
Calcium antagonists and neural control of circulation in essential hypertension 281
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate 268
Cardiopulmonary receptor regulation of renin release 265
Early alterations in left ventricular diastolic function in normotensive diabetic patients 262
Cardiovascular Remodeling after Endovascular Treatment for Thoracic Aortic Injury 261
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 257
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified 256
Prognostic significance of masked tachycardia in hypertension: Evidence from a prospective international registry 250
In healthy normotensive subjects age and blood pressure better predict subclinical vascular and cardiac organ damage than atherosclerosis biomarkers 250
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 247
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 246
The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study 243
A case of Pseudomonas Aeruginosa commercial tattoo infection 243
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 243
Heart rate as cardiovascular risk factor 242
Association Between Atrial, Ventricular and Vascular Morphofunctional Alterations in Rheumatoid Arthritis 241
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension 232
Differing associations for sport versus occupational physical activity and cardiovascular risk 232
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage 230
Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach 229
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings 227
Predictors of pwv progression over a three years follow up: focus on psychological characteristics 225
Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol 224
Psychological Predictors of Arterial Stiffness Progression over a Three Years Follow Up 221
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans 218
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 217
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol 215
Influence of cardiopulmonary receptors on the bradycardiac responses to carotid baroreceptor stimulation in man 215
2007 ESH-ESC guidelines for the management of arterial hypertension - The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) 213
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 213
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 213
Blood pressure response to labetalol in twice and three times daily administration during a 24‐hour period 213
Modification of arterial baroreflexes by captopril in essential hypertension 212
Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up 211
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 211
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 210
Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients 210
Mechanisms of antihypertensive action of beta-adrenergic blocking drugs: evidence against potentiation of baroreflexes 207
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 207
Two-Drug Combinations as First-Step Antihypertensive Treatment 207
Vitamin B12 deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report 206
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 205
Cardiovascular risk factor profile in an italian cohort of patients with rheumatoid arthritis: results of a three years follow-up 205
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 204
Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension 203
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: characteristics and mechanisms 201
The Pamela study: main findings and perspectives 201
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 201
Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report 201
Baroreflex and non-baroreflex modulation of vagal cardiac control after myocardial infarction 200
[Are plasma catecholamine levels capable of reflecting even small variations in sympathetic activity?] 200
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 200
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 199
Structural alterations of the retinal microcirculation in the "prehypertensive" high- normal blood pressure state 199
Treatment of hypertension: The ESH/ESC guidelines recommendations 199
Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state 199
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 198
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 198
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites 198
Cardiogenic reflexes and left ventricular hypertrophy 197
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 197
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies 197
Control of circulation by arterial baroreceptors and cardiopulmonary receptors in hypertension 197
Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis 196
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 195
Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure 194
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis 194
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 193
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 193
Alerting reaction and rise in blood pressure during measurement by physician and nurse 192
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis 192
Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease 191
Body fat mass is a strong and negative predictor of peak stimulated growth hormone and bone mineral density in healthy adolescents during transition period 191
The impact of arterial hypertension on left ventricular strain in patients with aortic stenosis and preserved ejection fraction. 191
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 191
Iron Overload Increases Sympathetic Nervous Activity: Study in Hemochromatosis Patients at Diagnosis and Iron Depletion 191
Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation 190
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: Rationale for further study on blood pressure targets of antihypertensive treatment after stroke 189
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study 189
Statins and the risk of diabetes: Evidence from a large population-based cohort study 188
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states 187
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 186
Blood pressure control in hypertension. Pros and cons of available treatment strategies 186
[Direct and continuous recording of arterial pressure in the diagnosis of pheochromocytoma] 186
Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients 185
Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan 185
Isolated systolic hypertension in the young: A position paper endorsed by the European Society of Hypertension 185
The association between 24-h blood pressure patterns and left ventricular mechanics 185
Multiple sampling improves norepinephrine reproducibility in essential hypertension: a comparison with the microneurographic technique 184
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium 184
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 184
Totale 22.462
Categoria #
all - tutte 439.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 439.035


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.259 0 0 0 0 0 0 0 0 0 821 1.021 417
2020/202114.875 987 810 1.289 1.399 1.077 1.379 1.737 1.478 1.203 1.537 784 1.195
2021/202210.935 791 951 1.293 930 814 744 526 679 638 762 978 1.829
2022/202314.314 2.112 4.076 1.131 1.153 862 2.360 194 817 889 109 400 211
2023/202411.472 322 293 482 532 1.772 2.742 2.129 325 1.204 226 212 1.233
2024/202521.513 1.760 3.941 1.278 1.366 2.575 926 1.539 1.204 3.523 3.401 0 0
Totale 112.766